The short answer: For most women with early womb (uterine or endometrial) cancer, robotic or other keyhole surgery is a good option: studies show it controls early womb cancer about as well as open surgery, with a shorter hospital stay and a quicker recovery. Open surgery is still the better choice when the womb is very large, the cancer seems to have spread inside the abdomen, or keyhole surgery would not be safe for you. Your surgeon decides this with you after looking at your scans, biopsy and general health. In Hindi this cancer is often searched as “bachedani ka cancer” (बच्चेदानी का कैंसर), and in Gujarati as ગર્ભાશયનું કેન્સર.
On this page
- Two Surgical Approaches, One Goal
- Open Surgery (Laparotomy)
- Robotic-Assisted Surgery
- How the Decision Is Made
Two Surgical Approaches, One Goal
When uterine (endometrial) cancer is diagnosed, surgery is the primary treatment for the vast majority of patients. The operation — total hysterectomy with bilateral salpingo-oophorectomy (removing the womb, cervix, both tubes and both ovaries) and checking the nearby lymph nodes — can be performed through a traditional open incision (laparotomy) or through small ports using a robotic-assisted platform. Understanding the differences helps patients make informed decisions in consultation with their surgeon. For the wider picture of diagnosis and treatment, see our guide to uterine cancer care.
Open Surgery (Laparotomy)
Open surgery involves a vertical midline incision from the umbilicus to the pubic bone. It provides the surgeon with direct access to the entire abdominal cavity and remains the approach of choice for:
- Very large uterine tumours or bulky pelvic masses
- Suspected extensive intra-abdominal disease requiring multi-visceral resection
- Patients with significant adhesions from prior surgery
- Settings where robotic or laparoscopic platforms are not available
Hospital stay is usually longer than after keyhole or robotic surgery, with full recovery taking 6–8 weeks.
Robotic-Assisted Surgery
Robotic surgery uses 4–5 small incisions (8–12 mm each) through which a camera and wristed instruments are inserted. The surgeon operates from a console with 3D high-definition visualisation and enhanced instrument articulation. For endometrial cancer, the robotic approach offers:
- Similar cancer control — for early-stage womb cancer, studies show keyhole surgery (robotic surgery is a form of keyhole surgery) removes the cancer and lymph nodes about as well as open surgery, with similar survival. This applies to womb cancer; for cervical cancer the evidence is different.
- Shorter hospital stay — often about 3–4 days; usually longer after open surgery
- Less blood loss — significantly lower transfusion rates
- Fewer wound complications — particularly important for obese patients, who account for a large proportion of endometrial cancer patients
- Faster return to normal activity — 2–3 weeks versus 6–8 weeks
Ordinary keyhole (laparoscopic) surgery gives many of the same benefits. Whether the robot adds anything depends mainly on how complex your operation is and on your surgeon’s experience.
How the Decision Is Made
The choice between open and robotic surgery is clinical, not cosmetic. It depends on the stage of the cancer, the size of the womb, body weight (body mass index), previous operations, and the surgeon’s assessment of what approach will achieve the best oncological outcome with the lowest risk. In Dr. Nishtha Tripathi Patel’s practice, most early-stage endometrial cancers are treated robotically — but the final decision is always individualised after thorough assessment. Before deciding, it helps to go through these questions to ask before robotic hysterectomy; our robotic surgery page also explains when robotic surgery is appropriate for other gynaecological cancers.
For a specialist consultation about uterine cancer surgery in Ahmedabad, contact Dr. Nishtha Tripathi Patel: +91 76988 00333.
Related and References
- Internal: Robotic surgery overview
- Internal: About Dr. Nishtha Tripathi Patel
- External: NCCN Guidelines for Gynaecological Cancers